About this Journal Submit a Manuscript Table of Contents
Scientifica
Volume 2013 (2013), Article ID 371569, 4 pages
http://dx.doi.org/10.1155/2013/371569
Research Article

Cardiovascular Risk in Psoriasis: A Population-Based Analysis with Assessment of the Framingham Risk Score

1Division of Rheumatology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
2Department of Health Sciences Research, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
3Department of Dermatology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA

Received 18 December 2012; Accepted 7 January 2013

Academic Editors: B. Z. Simkhovich and U. Tursen

Copyright © 2013 Elena Myasoedova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. N. Mehta, R. S. Azfar, D. B. Shin, A. L. Neimann, A. B. Troxel, and J. M. Gelfand, “Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the general practice research database,” European Heart Journal, vol. 31, no. 8, pp. 1000–1006, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. J. M. Gelfand, A. L. Neimann, D. B. Shin, X. Wang, D. J. Margolis, and A. B. Troxel, “Risk of myocardial infarction in patients with psoriasis,” Journal of the American Medical Association, vol. 296, no. 14, pp. 1735–1741, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. W. Q. Li, J. L. Han, J. E. Manson, et al., “Psoriasis and risk of nonfatal cardiovascular disease in U.S. women: a cohort study,” British Journal of Dermatology, vol. 166, no. 4, pp. 811–818, 2012.
  4. A. W. Armstrong, C. T. Harskamp, L. Ledo, J. H. Rogers, and E. J. Armstrong, “Coronary artery disease in patients with psoriasis referred for coronary angiography,” American Journal of Cardiology, vol. 109, no. 7, pp. 976–980, 2012.
  5. S. Prodanovich, R. S. Kirsner, J. D. Kravetz, F. Ma, L. Martinez, and D. G. Federman, “Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality,” Archives of Dermatology, vol. 145, no. 6, pp. 700–703, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Wakkee, R. M. C. Herings, and T. Nijsten, “Psoriasis may not be an independent risk factor for acute ischemic heart disease hospitalizations: results of a large population-based dutch cohort,” Journal of Investigative Dermatology, vol. 130, no. 4, pp. 962–967, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. H. M. Kremers, E. Myasoedova, C. S. Crowson, G. Savova, S. E. Gabriel, and E. L. Matteson, “The Rochester Epidemiology Project: exploiting the capabilities for population-based research in rheumatic diseases,” Rheumatology, vol. 50, no. 1, pp. 6–15, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Icen, C. S. Crowson, M. T. McEvoy, F. J. Dann, S. E. Gabriel, and H. Maradit Kremers, “Trends in incidence of adult-onset psoriasis over three decades: a population-based study,” Journal of the American Academy of Dermatology, vol. 60, no. 3, pp. 394–401, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. Heart Disease and Stroke Statistics: 2005 Update American Heart Association, 2006.
  10. R. B. D'Agostino, R. S. Vasan, M. J. Pencina et al., “General cardiovascular risk profile for use in primary care: the Framingham heart study,” Circulation, vol. 117, no. 6, pp. 743–753, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. R. S. Stern and A. Huibregtse, “Very severe psoriasis is associated with increased noncardiovascular mortality but not with increased cardiovascular risk,” Journal of Investigative Dermatology, vol. 131, no. 5, pp. 1159–1166, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Gisondi, S. Farina, M. V. Giordano, and G. Girolomoni, “Usefulness of the framingham risk score in patients with chronic psoriasis,” American Journal of Cardiology, vol. 106, no. 12, pp. 1754–1757, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Wakkee, R. M. C. Herings, and T. Nijsten, “Psoriasis may not be an independent risk factor for acute ischemic heart disease hospitalizations: results of a large population-based dutch cohort,” Journal of Investigative Dermatology, vol. 130, no. 4, pp. 962–967, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Mallbris, O. Akre, F. Granath et al., “Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients,” European Journal of Epidemiology, vol. 19, no. 3, pp. 225–230, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. A. W. Armstrong, C. Schupp, and B. Bebo, “Psoriasis comorbidities: results from the national psoriasis foundation surveys 2003 to 2011,” Dermatology, vol. 225, no. 2, pp. 121–126, 2012.
  16. P. Coto-Segura, E. Coto, V. Alvarez et al., “Apolipoprotein ε4 allele is associated with psoriasis severity,” Archives of Dermatological Research, vol. 302, no. 2, pp. 145–149, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Campalani, M. H. Allen, D. Fairhurst et al., “Apolipoprotein E gene polymorphisms are associated with psoriasis but do not determine disease response to acitretin,” British Journal of Dermatology, vol. 154, no. 2, pp. 345–352, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Han, T. Liu, and L. Lu, “Apolipoprotein E gene polymorphism in psoriasis: a meta-analysis,” Archives of Medical Research. In press. View at Publisher · View at Google Scholar
  19. N. N. Mehta, Y. Yu, R. Pinnelas et al., “Attributable risk estimate of severe psoriasis on major cardiovascular events,” American Journal of Medicine, vol. 124, no. 8, pp. 775.e1–775.e6, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Maradit-Kremers, M. Icen, F. C. Ernste, R. A. Dierkhising, and M. T. McEvoy, “Disease severity and therapy as predictors of cardiovascular risk in psoriasis: a population-based cohort study,” Journal of the European Academy of Dermatology and Venereology, vol. 26, no. 3, pp. 336–343, 2012.
  21. R. S. Stern, “Psoriasis is not a useful independent risk factor for cardiovascular disease,” Journal of Investigative Dermatology, vol. 130, no. 4, pp. 917–919, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. C. S. Crowson, E. L. Matteson, V. L. Roger, T. M. Therneau, and S. E. Gabriel, “Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis,” American Journal of Cardiology, vol. 110, no. 3, pp. 420–424, 2012.
  23. A. B. Kimball, A. Guerin, D. Latremouille-Viau et al., “Coronary heart disease and stroke risk in patients with psoriasis: retrospective analysis,” American Journal of Medicine, vol. 123, no. 4, pp. 350–357, 2010. View at Publisher · View at Google Scholar · View at Scopus